ogistics of Circulating Tumor Cells in Peripheral Blood Collection in Patients with Metastatic Prostate Cancer

• Conditions: gemetastaseerd prostaatkanker; metastatic prostate cancer; 10027476

• Registration Number: NL-OMON40759
• Lead Sponsor: eids Universitair Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 10

Inclusion Criteria

Male aged 18 years or older
Metastatic prostate cancer with a PSA >5ug/L
Written informed consent

Exclusion Criteria

None

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The diagnostic accuracy of Detektor CANCER02 in comparison to Detektor CANCER01<br /><br>for the detection of CTCs in peripheral blood stream in patients with advanced<br /><br>PC.<br /><br></p><br>

Secondary Outcome Measures

Name	Time	Method
<p>None</p><br>